Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Beijing 302 Hospital · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
hr+/her2- advanced breast cancer, post-cdk4/6 inhibitor, dalpiciclib, hadci, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834298
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.